Efficacy, tolerability and safety of long-term darifenacin treatment in older patients with overactive bladder: analysis of results from a 2-year, open-label extension study
Dwyer P1, Lheritier K2, Steel M2 1. Mercy Hospital for Women, Melbourne, Australia, 2. Novartis Pharma AG, Basel, Switzerland
|
|
Abstract 125
|
|
|
Overactive Bladder - Basic Science and Clinical Practice:Main Auditorium
Scientific Podium Poster Session 14
|
|
|
Friday 1st December 2006 |
|
|
09:15 - 09:22 |
|
|